[Possibilities of pharmacological prevention of oxalate calculi].
D000464:Alginates / Q000627:therapeutic use; D000493:Allopurinol / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D004035:Diet Therapy; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007475:Ion Exchange Resins / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D008297:Male; D008751:Methylene Blue / Q000627:therapeutic use; D010070:Oxalates / Q000378:metabolism*; D010710:Phosphates / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D014545:Urinary Calculi / Q000517:prevention & control*
D000464:Alginates; D004232:Diuretics; D007475:Ion Exchange Resins; D010070:Oxalates; D010710:Phosphates; D000493:Allopurinol; D012964:Sodium; D008274:Magnesium; D011736:Pyridoxine; D002118:Calcium; D008751:Methylene Blue
Möglichkeiten der medikamentösen Oxalatsteinprophylaxe.